Multinucleated cells in pigmented villonodular synovitis and giant cell tumor of tendon sheath express features of osteoclasts

American Journal of Pathology

Volumn 150, Issue 4, 1997, Pages 1383-1393

  Darling, Jama M ^a,b   Goldring, Steven R ^c   Harada, Yoshitada ^c   Handel, Malcolm L ^a,b   Glowacki, Julie ^a   Gravallese, Ellen M ^a,b  

^a Department of Cancer Biology ^*

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN EXPRESSION; ARTICLE; BONE CYST; CELL TYPE; GIANT CELL TUMOR; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MACROPHAGE; MONOCYTE; MULTINUCLEAR CELL; OSTEOBLAST; OSTEOLYSIS; PHENOTYPE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SYNOVITIS; TENDON SHEATH;

EID: 0030896236     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Jaffe HL, Lichtenstein L, Sutro CJ: Pigmented villonodular synovitis, bursitis, and tenosynovitis. Arch Pathol 1941, 31:731-765
2. Gehweiler JA, Wilson JW: Diffuse Particular pigmented villonodular synovitis. Radiology 1969, 93:845-851
3. Smith JH, Pugh DG: Roentgenographic aspects of articular pigmented villonodular synovitis. Am J Roentgenol 1962, 87:1146-1156
4. Byers PD, Cotton RE, Deacon OW, Lowy M, Newman PH, Sissons HA, Thomson AD: The diagnosis and treatment of pigmented villonodular synovitis. J Bone Joint Surg [Br] 1968, 50:290-305
5. Eisenstein R: Giant-cell tumor of tendon sheath: its histogenesis as studied in the electron microscope. J Bone Joint Surg [Am] 1968, 50:476-486
6. Nielsen AL, Kiaer T: Malignant giant cell tumor of synovium and locally destructive pigmented villonodular synovitis: ultrastructural and immunohistochemical study and review of the literature. Hum Pathol 1989, 20:765-771
7. Jozsa L: Immunohistochemical characterization of pigmented villonodular synovitis. Zentralbl Pathol 1992, 138:119-123
8. Ling L, Klein MJ, Sissons HA, Steiner GC: Lysozyme and α-1-antitrypsin in giant-cell tumor of bone and in other lesions that contain giant cells. Arch Pathol Lab Med 1986, 110:713-718
9. Tashiro H, Iwasaki H, Kikuchi M, Ogata K, Okazaki M: Giant cell tumors of tendon sheath: a single and multiple-immunostaining analysis. Pathol Int 1995, 45:147-155
10. O'Connell JX, Fanburg JC, Rosenberg AE: Giant cell tumor of tendon sheath and pigmented villonodular synovitis: immunophenotype suggests a synovial cell origin, Hum Pathol 1995, 26:771-775
11. Dorwart RH, Genant HK, Johnston WH, Morris JM: Pigmented villonodular synovitis of synovial joints: clinical, pathologic, and radiologic features, Am J Roentgenol 1984, 143:877-885
12. Gitelis S, Heligman D, Morton T: The treatment of pigmented villonodular synovitis of the hip: a case report and literature review. Clin Orthop 1989, 239:154-160
13. Myers BW, Masi AT, Feigenbaum SL: Pigmented villonodular synovitis and tenosynovitis: a clinical epidemiologic study of 166 cases and literature review. Medicine 1980, 59:223-238
14. Chung SMK, Janes JM: Diffuse pigmented villonodular synovitis of the hip joint: review of the literature and report of four cases. J Bone Joint Surg [Am] 1965, 47:293-303
15. Scott PM: Bone lesions in pigmented villonodular synovitis. J Bone Joint Surgery [Br] 1968, 50:306-311
16. McMaster PE: Pigmented villonodular synovitis with invasion of bone: report of six cases. J Bone Joint Surg [Am] 1960, 42:1170-1183
17. Darling JM, Glimcher LH, Shortkroff S, Albano B, Gravallese EM: Expression of metalloproteinases in pigmented villonodular synovitis. Hum Pathol 1994, 25:825-830
18. Wood GS, Beckstead JH, Medeiros LJ, Kempson RL, Warnke RA: The cells of giant cell tumor of tendon sheath resemble osteoclasts. Am J Surg Pathol 1988, 12:444-452
19. Carstens PHB: Giant cell tumors of tendon sheath: an electron microscopical study of 11 cases. Arch Pathol Lab Med 1978, 102:99-103
20. Hattersley G, Chambers TJ: Generation of osteoclastic function in mouse bone marrow cultures: multinuclearity and tartrate-resistant acid phosphatase are unreliable markers for osteoclastic differentiation. Endocrinology 1989, 124:1689-1696
21. Suda T, Takahashi N, Martin TJ: Modulation of osteoclast differentiation. Endocr Rev 1992, 13:66-80
22. Bianco P, Costantini M, Dearden LC, Bonucci E: Expression of tartrate-resistant acid phosphatase in bone marrow macrophages. Bas Appl Histochem 1987, 31:433-440
23. Athanasou NA, Quinn J, Horton MA, McGee JOD: New sites of cellular vitronectin receptor immunoreactivity detected with osteoclast-reacting monoclonal antibodies 13C2 and 23C6. Bone Mineral 1990, 8:7-22
24. Horton MA, Helfrich MH: Antigenic markers of osteoclasts. Biology and Physiology of the Osteoclast. Edited by BR Rifkin, CV Gay. Boca Raton, FL, CRC Press, 1992, pp 33-54
25. Lin HY, Harris TL, Flannery MS, Aruffo A, Kaji EH, Gorn A, Kolakowski LF Jr, Lodish HF, Goldring SR: Expression cloning of an adenylate cyclase-coupled calcitonin receptor. Science 1991, 254:1022-1024
26. Gorn AH, Lin HY, Yamin M, Auron PE, Flannery MR, Tapp DR, Manning CA, Lodish HF, Krane SM, Goldring SR: Cloning, characterization, and expression of a human calcitonin receptor from an ovarian carcinoma cell line. J Clin Invest 1992, 90:1726-1735
27. 3 in osteoclast-like multinucleated cells formed from mouse bone marrow cells. Endocrinology 1988, 123:1504-1510
28. Hattersley G, Chambers TJ: Calcitonin receptors as markers for osteoclastic differentiation: correlation between generation of bone-resorptive cells and cells that express calcitonin receptors in mouse bone marrow cultures. Endocrinology 1989, 125:1606-1612
29. Lee SK, Goldring SR, Lorenzo JA: Expression of the calcitonin receptor in bone marrow cell cultures and in bone: a specific marker of the differentiated osteoclast that is regulated by calcitonin. Endocrinology 1995, 136:4572-4581
30. Takahashi S, Goldring S, Katz M, Hilsenbeck S, Williams R, Roodman GD: Downregulation of calcitonin receptor mRNA expression by calcitonin during human osteoclast-like cell differentiation. J Clin Invest 1995, 95:167-171
31. Ikegame M, Rakopoulos M, Zhou H, Houssami S, Martin TJ, Moseley JM, Findlay DM: Calcitonin receptor isoforms in mouse and rat osteoclasts. J Bone Mineral Res 1995, 10:59-65
32. Holtrop ME, Raisz LG, Simmons HA: The effects of parathyroid hormone, colchicine, and calcitonin on the ultrastructure and the activity of osteoclasts in organ culture. J Cell Biol 1974, 60:346-355
33. Glowacki J, Rey C, Glimcher MJ, Cox KA, Lian J: A role for osteocalcin in osteoclast differentiation. J Cell Biochem 1991, 45:292-302
34. Ono SJ, Bazil V, Sugawara M, Strominger JL: An isotype-specific trans-acting factor is defective in a mutant B cell line that expresses HLA-DQ, but not -DR or -DP. J Exp Med 1991, 173:629-637
35. Norton MA, Lewis D, McNulty K, Pringle JAS, Chambers TJ: Monoclonal antibodies to osteoclastomas (giant cell bone tumours): definition of osteoclast-specific cellular antigens. Cancer Res 1985, 45:5663-5669
36. Piccinini LA, Goldsmith NK, Schachter BS, Davies TF: Localization of HLA-DR α-chain messenger ribonucleic acid in normal and autoimmune human thyroid using in situ hybridization. J Clin Endocrinol Metab 1988, 66:1307-1315
37. Gravallese EM, Darling JM, Ladd AL, Katz JN, Glimcher LH: In situ hybridization studies of stromelysin and collagenase messenger RNA expression in rheumatoid synovium. Arthritis Rheum 1991, 34:1076-1084
38. Goldring SR, Roelke MS, Petrison KK, Bhan AK: Human giant cell tumors of bone: identification and characterization of cell types. J Clin Invest 1987, 79:483-491
39. Chomczynski P, Sacchi NP: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987, 162:156-159
40. Ling L, Klein MJ, Sissons HA, Steiner GC, Winchester RJ: Expression of la and monocyte-macrophage lineage antigens in giant cell tumor of bone and related lesions. Arch Pathol Lab Med 1988, 112:65-69
41. Schumacher HR, Lotke P, Athreya B, Rothfuss S: Pigmented villonodular synovitis: light and electron microscopic studies, Semin Arthritis Rheum 1982, 12:32-43
42. Reginato A, Martinez V, Schumacher HR, Torres J: Giant cell tumor associated with rheumatoid arthritis. Ann Rheum Dis 1974, 33:333-341
43. Alguacil-Garcia A, Unni KK, Goellner JR: Giant cell tumor of tendon sheath and pigmented villonodular synovitis: an ultrastructural study. Am J Clin Pathol 1978, 69:6-17
44. Geschickter CF, Copeland MM: Tumors of Bone, ed 3. Philadelphia, JB Lippincott, 1949, p 357
45. Goldring SR, Schiller AL, Mankin HJ, Dayer J-M, Krane SM: Characterization of cells from human giant cell tumors of bone. Clin Orthop Rel Res 1986, 204:59-75
46. Norton M: Current status review. Vitronectin receptor: tissue specific expression or adaptation to culture? Int J Exp Pathol 1990, 71:741-759
47. Athanasou NA, Quinn J: Immunophenotypic differences between osteoclasts and macrophage polykaryons: immunohistological distinction and implications for osteoclast ontogeny and function. J Clin Pathol 1990, 43:997-1003
48. Amir G, Rosenmann E: Osteoclast-like giant cell tu- mour of the urinary bladder. Histopathology 1990, 17:413-418
49. Esmaili JH, Hafez GR, Warner TF: Anaplastic carcinoma of the thyroid with osteoclast-like giant cells. Cancer 1983, 52:2122-2128
50. Van de Wijngaert FP, Burger EH: Demonstration of tartrate-resistant acid phosphatase in un-decalcified, glycolmethacrylate-embedded mouse bone: a possible marker for (pre)osteoclast identification. J Histochem Cytochem 1986, 34:1317-1323
51. Athanasou NA, Quinn J, Ferguson DJP, McGee JOD: Bone resorption by macrophage polykaryons of giant cell tumor of tendon sheath. Br J Cancer 1991, 63:527-533
52. Connor JR, Dodds RA, James IE, Gowen M: Human osteoclast and giant cell differentiation. The apparent switch from nonspecific esterase to tartrate resistant acid phosphatase activity coincides with the In situ expression of osteopontin mRNA. J Histochem Cyto-chem 1995, 43:1193-1201